DA Grimes, J Benson, S Singh, M Romero
DA Grimes, J Benson, S Singh, M Romero
DA Grimes, J Benson, S Singh, M Romero
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Medical abortion by Misoprostol (MO) (Cytotec*)<br />
in Brazil<br />
• MO (prostaglandin) introduced in Brazil in 1986, rapidlly became available over the counter<br />
• Women recognised its ective abortifacient properties and began to use the drug<br />
• They self-administer the drug orally; seeking medic assistance in case of uterine bleeding<br />
• By 1990, 70% of women treated in hospital for abortion complications in reported use of<br />
MO. This led the MoHof Brazil to restrict its sale in 1991. Some states banned the drug.<br />
• However, restricting did not prevent the use : MO remained available at higher prices on<br />
the black market. Consequently, in some states of Brazil, abortion complications increased<br />
and abortion-related deaths tripled after MO restriction.<br />
• MO globally the severity of UA complications, and the hospital admissions: previously,<br />
foreign bodies inserted into the cervix, caused bleeding urging curettage & infection<br />
• The wide use of MO for abortion has been associated with improved health for women.<br />
• Women have widely accepted medical abortion because of it is similar to spontaneous<br />
abortion.<br />
IFMT-MS.Sémin.Mère-<br />
Enft.déc.2006<br />
14
Change language